Roche

CINtec® Histology is a pioneering diagnostic brand specializing in the assessment of cervical biopsy specimens. It is the sole 510(k) p16 immunohistochemistry biomarker test cleared for clinical use in this area, providing critical insights in diagnosing cervical precancer. Pathologists utilizing CINtec® Histology benefit from enhanced diagnostic accuracy, improving both diagnostic sensitivity and consistency, crucial for effective patient management.

The brand offers a range of products, including the CINtec® Histology test for in vitro diagnostic (IVD) applications, which ensures a more objective interpretation of cervical biopsies. This advanced technology significantly aids in identifying high-grade cervical disease while reducing the likelihood of misdiagnoses. By employing CINtec® Histology, healthcare professionals can confidently ensure that the right patients receive treatment, ultimately optimizing outcomes for cervical cancer patients.

CINtec® Histology is committed to advancing diagnostic practices through innovation and providing essential resources for healthcare practitioners, including training modules and comprehensive support materials.